Galectin Therapeutics to Present at the Singular Research Summer Conference
July 07, 2017 12:00 ET
|
Galectin Therapeutics
NORCROSS, Ga., July 07, 2017 (GLOBE NEWSWIRE) -- Galectin Therapeutics Inc. (NASDAQ:GALT), the leading developer of therapeutics that target galectin proteins, today announced that Harold Shlevin,...